MedTrace Logo

Post-Market Study of Alcon Intraocular Lenses

NCT05414565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-07-09

No results posted yet for this study

Summary

The purpose of the study is to evaluate clinical and functional performance in real-world conditions in participants who have been implanted with Acrysof IQ Vivity (Extended Vision) IOLs compared with Alcon Aspheric Monofocal IOLs.

Conditions

  • Visual Acuity

Interventions

DEVICE

Vivity IOL

Commercially available extended vision IOL

DEVICE

Aspheric monofocal IOL

Commercially available aspheric IOL

Sponsors & Collaborators

  • Queensland University of Technology

    collaborator OTHER

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Director of Clinical Projects, Surgical · Alcon Research, LLC

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-15
Primary Completion
2024-04-15
Completion
2024-04-15

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05414565 on ClinicalTrials.gov